Dr Nidhan Biswas, the lead investigator from NIBMG, emphasised how this study moves India closer to personalised cancer care.
3 天on MSN
Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen ...
Dutch health insurers have stopped fully covering two of three medicines for metastatic hormonal breast cancer. Since January ...
Researchers analyzed data on 215 women diagnosed with stages 0-III breast cancer between January 2000 and October 2024 who ...
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...
In this video, Aruna Padmanabhan, MD, discusses the effectiveness of cyclin-dependent kinase inhibitors in the treatment of metastatic hormone-positive breast cancer. In this video, Aruna ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果